Le Lézard
Classified in: Covid-19 virus

FINAL DEADLINE TUESDAY: The Schall Law Firm Encourages Investors in Mullen Automotive, Inc. with Losses of $100,000 to Contact the Firm


LOS ANGELES, CA / ACCESSWIRE / July 1, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Mullen Automotive, Inc. f/k/a Net Element, Inc. ("Mullen" or "the Company") (NASDAQ:MULN) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, Friday, July 1, 2022, Press release picture

Investors who purchased the Company's securities between June 15, 2020 and April 6, 2022, inclusive (the ''Class Period''), are encouraged to contact the firm before July 5, 2022.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Mullen overstated both its production abilities and timeline. The Company overstated its business activities with partners such as Qiantu Motors. The Company exaggerated the strength of its battery technology. The Company's Dragonfly K50 was not exclusively delayed by the COVID-19 pandemic. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Mullen, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

SOURCE: The Schall Law Firm



View source version on accesswire.com:
https://www.accesswire.com/707427/FINAL-DEADLINE-TUESDAY-The-Schall-Law-Firm-Encourages-Investors-in-Mullen-Automotive-Inc-with-Losses-of-100000-to-Contact-the-Firm


These press releases may also interest you

19 avr 2024
Voxtur Analytics Corp. , a North American technology company creating a more transparent and accessible real estate lending ecosystem, is pleased to announce that it has engaged the services of ICP Securities Inc. ("ICP") to provide automated market...

19 avr 2024
On April 19, 2024, the board of directors of Portland General Electric Company declared a quarterly common stock dividend of $0.50 per share, representing an increase of 5.3%, or $0.10 per share, on an annualized basis. The company's dividend is...

19 avr 2024
Adyton Resources Corporation  ("Adyton" or the "Company") announces it has closed its previously announced non-brokered private placement offering, pursuant to which it has issued 50,000,000 common shares of the Company ("Shares") at a price of...

19 avr 2024
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

19 avr 2024
Lion Group Holding Ltd. ("Lion" or "the Company") , the operator of an all-in-one trading platform that offers a wide spectrum of products and services, today announced that on April 18, 2024, it received a delinquency notification letter from the...

19 avr 2024
Cosmos Health Inc. ("Cosmos Health" or the "Company'') , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor...



News published on and distributed by: